• Needham & Company LLC Reiterates "Hold" Rating for Sage Therapeutics (NASDAQ:SAGE)

    Source: Buzz FX / 08 Oct 2024 15:21:11   America/Chicago


    Needham & Company LLC Reiterates "Hold" Rating for Sage Therapeutics (NASDAQ:SAGE) Written by MarketBeat October 8, 2024 Share Link copied to clipboard. Sage Therapeutics ( NASDAQ:SAGE - Get Free Report ) 's stock had its "hold" rating reaf
    Read more...
Share on,